Caxton Associates LP Makes New $949,000 Investment in Colgate-Palmolive (NYSE:CL)

Caxton Associates LP acquired a new position in shares of Colgate-Palmolive (NYSE:CLGet Rating) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 11,842 shares of the company’s stock, valued at approximately $949,000.

Several other large investors have also modified their holdings of CL. Creative Planning raised its stake in shares of Colgate-Palmolive by 36.5% in the 2nd quarter. Creative Planning now owns 198,312 shares of the company’s stock valued at $15,893,000 after buying an additional 53,072 shares in the last quarter. AQR Capital Management LLC increased its position in shares of Colgate-Palmolive by 12.3% during the 2nd quarter. AQR Capital Management LLC now owns 2,034,959 shares of the company’s stock worth $161,698,000 after purchasing an additional 223,446 shares in the last quarter. Candlestick Capital Management LP acquired a new stake in shares of Colgate-Palmolive during the 2nd quarter worth about $54,095,000. Hotaling Investment Management LLC acquired a new stake in shares of Colgate-Palmolive during the 2nd quarter worth about $328,000. Finally, Tradewinds LLC. acquired a new stake in shares of Colgate-Palmolive during the 2nd quarter worth about $3,335,000. 78.62% of the stock is owned by institutional investors.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, insider Sally Massey sold 656 shares of the business’s stock in a transaction dated Tuesday, September 13th. The stock was sold at an average price of $77.58, for a total transaction of $50,892.48. Following the completion of the transaction, the insider now owns 7,913 shares of the company’s stock, valued at $613,890.54. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.32% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

CL has been the subject of a number of recent analyst reports. Barclays increased their target price on shares of Colgate-Palmolive from $72.00 to $76.00 and gave the stock an “equal weight” rating in a research report on Tuesday, November 1st. Credit Suisse Group reduced their target price on shares of Colgate-Palmolive from $88.00 to $85.00 and set an “outperform” rating on the stock in a research note on Tuesday, October 18th. StockNews.com lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Wednesday. JPMorgan Chase & Co. raised shares of Colgate-Palmolive from a “neutral” rating to an “overweight” rating and set a $79.00 target price on the stock in a research note on Thursday, October 13th. Finally, The Goldman Sachs Group reduced their price objective on shares of Colgate-Palmolive from $91.00 to $81.00 and set a “buy” rating on the stock in a research note on Monday, October 10th. Ten analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $82.58.

Colgate-Palmolive Price Performance

Shares of CL opened at $78.14 on Friday. The company has a current ratio of 1.17, a quick ratio of 0.71 and a debt-to-equity ratio of 7.81. The company’s fifty day simple moving average is $73.80 and its 200 day simple moving average is $76.73. Colgate-Palmolive has a 1-year low of $67.84 and a 1-year high of $85.61. The company has a market cap of $65.26 billion, a price-to-earnings ratio of 33.97, a PEG ratio of 7.23 and a beta of 0.53.

Colgate-Palmolive (NYSE:CLGet Rating) last announced its earnings results on Friday, October 28th. The company reported $0.74 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.73 by $0.01. The company had revenue of $4.46 billion during the quarter, compared to analysts’ expectations of $4.47 billion. Colgate-Palmolive had a net margin of 10.87% and a return on equity of 304.29%. Colgate-Palmolive’s quarterly revenue was up .9% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.81 earnings per share. On average, research analysts forecast that Colgate-Palmolive will post 2.97 earnings per share for the current fiscal year.

About Colgate-Palmolive

(Get Rating)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

See Also

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.